Primary Ciliary Dyskinesia Market Overview – Key Futuristic Trends and Opportunities

Market Research Future adds new report of “Primary Ciliary Dyskinesia Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Primary ciliary dyskinesia (PCD), also kown as immotile ciliary syndrome or Kartagener syndrome. Primary ciliary dyskinesia is a rare disorder and is a type of chronic respiratory tract infections, normally occurs in internal organs of human body. The major symptoms of this condition are caused by abnormal cilia and flagella. Normally cilia are microscopic, finger-like projections that stick out from the surface of cells. They are found in the linings of the airway, the reproductive system, and other organs and tissues. Flagella are tail-like structures, similar to cilia that propel sperm cells forward.

In some cases, mutations in the genes can cause primary ciliary dyskinesia result in defective cilia that move abnormally or are unable to move. As cilia have many important functions within the body, defects in these cell structures cause diseased condition

Competitive Analysis:

Some of the key players in this market are AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline, Novartis AG, Pfizer Inc., Teva UK Limited, Masimo Corporation (U.S.), BD (U.S.), Portex Division of Smith Industries Medical System, Teruma Medical Corporation, HTL STREFA SA, Greinier Bio One International GmBH., F. Hoffman La Roche AG, Bayer AG., Acare Technology Co., Medline Industries Inc., Ltd., Hill-Rom Holdings Inc., Allied Healthcare Inc., Rotech Healthcare Inc., and others.

Market Highlight:

Increasing prevalence of respiratory tract diseases is one of the major factors for the growth of the market during the forecast period. According to the Centers for Disease Control and Prevention (2014), 9.3 million adults diagnosed with respiratory problems. Whereas, 147,101 deaths occurred due to chronic lower respiratory diseases.It is predicted to be the 3rd most death causing factor.

According to the World Health Organization (WHO), over 7 million deaths occur each year of which more than 6 million deaths result from direct use of tobacco. Moreover, According to Eurostat’s, (2014), COPD (Chronic Obstructive Pulmonary Disease) affected more than 200 million people worldwide and is one of the major diseases whose prevalence is increasing across the globe.

However, high cost of the current treatment methods and lack of awareness about rare respiratory diseases such as primary ciliary dyskinesia may hamper the market growth over the review period.

The global primary ciliary dyskinesia market is expected to grow at a CAGR of ~6.7% during the forecast period 2017-2023.

Market Segmentation:

The global primary ciliary dyskinesia market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, the market is segmented into genetic testing, electron microscopy, and others. On the basis of treatment, the market is categorized into drug treatment, radiotherapy, chemotherapy, others. On the basis of drug treatment, it is further segmented into clarithromycin, erythromycin and azithromycin, and others. On the basis of end user, the market is segmented into hospitals & clinics, research centers, and others.

Regional Analysis

The Americas dominates the global primary ciliary dyskinesia market owing to the presence of strong economic condition, huge development in healthcare domain, and focus of research institutions on updating technology for rare diseases diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, availability of skilled healthcare professional are boosting the growth of the market.

Europe holds the second largest primary ciliary dyskinesia market across the globe due to encouraging government policies for research & development and healthcare professionals by various European countries such as France and Germany. Moreover, according to Eurostat’s, (2014), over 401000 deaths were caused by respiratory system diseases, which are equivalent to 8.0 % of all deaths. Proportion of deaths in the UK from respiratory diseases is considerably higher than the other European countries, which will drive the market growth in this region during the forecast period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Eye Allergy Treatment Market Outlook and Global Foresight to 2023

Market Research Future adds new report of “Eye Allergy Treatment Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Eye allergies develop when the body’s immune system becomes sensitized and overreacts to something in the environment that typically causes no problem in most people. An allergic reaction can occur when that “something” (called an allergen) comes in contact with antibodies attached to the mast cells in your eyes; the cells respond by releasing histamine and other substances or chemicals that cause tiny blood vessels to leak and the eyes to become itchy, red and watery.

Competitive Analysis:

Some of the key players in this market are: ALLERGAN (Republic of Ireland), Johnson & Johnson Vision Care, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Regeneron Pharmaceuticals, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Santen Pharmaceutical Co., Ltd.(Japan), Valeant (Canada) Shire (Republic of Ireland), and others.

Market Segments:   

Global Eye Allergy Treatment market has been segmented on the basis of type which comprise seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. Vernal keratoconjunctivitis includes palpebral, limbal, corneal, and others. On the basis of treatment, the market has been segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. Decongestants are further sub-segmented into with or without antihistamines. Allergy shots (immunotherapy) is sub-segmented into Subcutaneous Immunotherapy Treatment (SCIT) and Sublingual Immunotherapy Treatment (SLIT). On the basis of end user, it is segmented into eye hospitals & clinics, medical institutes, research centers, and others.

Market Highlight:

Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Some of the common eye allergy symptoms are redness, itching, and burning.

Increasing prevalence of various eye allergies are key driver for the market while some other factors like increasing awareness, technological advancements, new therapies, and increasing healthcare expenditure are also major driving forces of global eye allergy treatment market.

The global eye allergy treatment market is expected to grow at the CAGR of ~5.2% during the forecast period and estimated to reach US$ 6845.3million by 2023.

Study objectives of global Eye Allergy Treatment market:

To provide detailed analysis of the global eye allergy treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments. To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global eye allergy treatment market. To provide detailed analysis of the market segmented by type, treatment, end user, and its sub-segments. To provide a detailed analysis of global eye allergy treatment market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc. To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

Regional analysis of global eye allergy treatment market:  

Considering the global scenario of the market, the Americas dominate global market due to various factors such as large amount of money invested in R&D, new approvals for various dugs and medicine etc. European market is second largest and is expected to grow significantly during the forecast period. Due to rapidly developing healthcare facilities, rising healthcare expenditure, increasing investment in technology advancement, Asia Pacific region is the fastest growing in global eye allergy market. Middle East & Africa market is also growing but is expected to grow slower than the global average.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Safety Lancet Market by Key Players, Growth, Regions and Forecast to 2023

Global Safety Lancet Market Information, by Type (Push Button Safety Lancet, Pressure Activated Safety Lancet), by End User – Forecast to 2023

Market Research Future adds new report of “Safety Lancet Market Research Report – Global Forecast to 2023” it contains Company information, geographical data and Table of Content

The global market of safety lancet is projected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8% during the forecast period 2017-2023.

Safety lancet is a disposable contrivance used for collecting capillary blood samples by doctors or other medical professionals. This is an intact object to the prevention from needle injury problems. Safety lancet eradicates the injuries and infections caused by injections.

Safety Lancet Market-Overview:

Various reasons are helping behind the grand success of safety lancet market. The safety lancet becomes automatically inactive after it is used once. So there is no way to use it twice. This helps the doctors to maintain proper hygiene needed for the patient as a result patients are highly demanding for the use of safety lancet which is further propelling the market growth. Safety lancet contains self-retracting needles which reduces the hazard of cross contamination and other needle related injuries. Safety lancet is created in a way that it goes slightly under the skin and pulls as much of blood is required without leaving some deep injuries inside the skin. This is a great option for those who has fear in needle, as a result hospitals are hugely adopting this safety lancet. Another aspect helping the acceptance of safety lancet in market is that this has high speed penetration which helps to abbreviate the pain which comes from regular injections. The sharp injury prevention aspect of safety lancet is expanding its market growth globally.

The cost of safety lancet is really high. So as a result though it is painless and hazardless people from undeveloped countries can’t afford them. Countries like Africa where there is scarcity of food people can’t even think about adopting this new innovative technology. Other than this another factor demolishing the market growth of safety lancet is that it is not always available. This availability problem is somehow hindering the market growth of safety lancet.

Safety Lancet Market- Regional Analysis:

Asia Pacific has countries like India, China where high population is giving rise to the adoption of safety lancet. South Korea has done some huge advancement which is working as a reason behind the huge growth of safety lancet market in Asia Pacific.

North America is massively contributing in the market growth of safety lancet market. Health care clinics and hospitals in US are considerably adopting this new medical technology as patients over there are highly aware about hygiene. Europe is also contributing in the market growth of safety lancet. Germany, France and Italy are embracing this safety lancet in their hospitals and clinics.

 

Safety Lancet Market-Competitive Analysis: In 2007, GMMC chucked the LANZO lancing device and in 2011 GMMC initiated LANZO safety lancet and is recognized among the best suppliers of safety lancet in Korean market.

Major contributors in this market are: F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Tourism Market by Key Players, Growth, Regions and Forecast to 2023

Medical tourism market information: by treatment types (orthopedic/spine treatments, oncology/cancer treatments) – Forecast till 2023

Market Research Future adds new report of “Medical Tourism Market Research Report- Global forecast till 2023” it contains Company information, geographical data and Table of Content

The Market is forecasted to account for an upsurge accretion of USD 226,762.7 Million by 2023with a whooping double digit CAGR of 21.4% during 2017 and 2023.

Medical Tourism isn’t new to the world; from ages individuals have been voyaging abroad for restorative medications. However, finished the most recent couple of years the world is resounding with the term called Medical Tourism or medicinal travel. The scene for Medical Tourism has changed altogether attributable to a different reasons. The Medical Tourism showcase is blasting and anticipated that would increase facilitate noticeable quality over the estimate time frame credited to the monetary development over the globe. Monetary development is likewise in charge of the regularly changing inclinations of goals individuals go to.

Asklepios Kliniken Verwaltungsgesellschaft mbH (Germany), Fortis Healthcare (India), Gleneagles Global Hospitals Group. (Singapore), Prince Court Medical Centre (Malaysia), Samitivej PCL (Thailand), Christus Muguerza (Mexico), and Anadolu Medical Center (Turkey) are some of the prominent players competing in the Global Medical Tourism Market and are profiled in MRFR Analysis.

As showed by a flow report appropriated by the Market Research Future, The overall market of Medical Tourism is foreseen to gather at a quick pace in the midst of the guess time period (2017 – 2023). The dazzling accumulations of Medical Tourism Market are attributed to the advanced and canny headways. The extending globalization, growing overall capital financing and movement in therapeutic development has provoked the headway of all inclusive human administrations organizations. Remedial Tourism Market is essentially determined by the Medical enormity close by overall accreditation. Growing affirm workplaces is a prime factor driving the market advancement of Medical Tourism. High treatment costs and long sitting tight conditions for helpful procedure, being the two main issue in driving therapeutic tourism, are in like manner maintained by less requesting and more affordable worldwide travel. While the U.K’s. people needs to head out abroad to sidestep long holds up, patients from the U.S. go outside for benefitting of drugs at more affordable costs.

Medical Tourism Market – Regional Analysis: The Asia Pacific region accounted for the largest share of the global medical tourism market, which had a lion share of 43.7% in 2016. This growth was attributed to heavy investment in infrastructure development, rising economy, technology up gradation, low cost and quality medical services, and government initiative to promote medical tourism in this region. Medical Tourism Market in India is booming attributed to the latest, low-cost technologies. The industry has evolved into a fully-fledged luxury market. Latest medical technologies in Indian hospitals at a lower cost is majorly contributing towards the country emerging as the premier Medical Tourism hub of the world. Treatments provided in India from accredited facilities are at par with any developed country in the world but at a lower cost, thus making giving Medical Tourism a competitive advantage over others. The digitisation in the health industry will also make the flow of foreign patients easier in the upcoming time.

America holds the second position in the medical tourism, which is followed by Europe. Central and South American countries such as Mexico, Costa Rica, and Brazil are some of the most popular destinations for Americans and Canadians. The American medical tourism market is expected to grow till USD 102,496.8 million at a CAGR of 22% by end of the 2023.

Europe is the growing market for the medical tourism. Since people from Western Europe are traveling to America to seek cost-effective treatments, which has relaxed the growth of the market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Metastases Spinal Tumor Market Overview, Analysis and Forecasts to 2023

Market Research Future adds new report of “Metastases Spinal Tumor Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

The global metastases spinal tumor market is expected to grow at the CAGR of ~3.2% during the forecast period and is estimated to reach USD 1547.8 million by 2023.

Metastases spinal tumor is one of the most common problems in oncology. Approximately 5%-10% of the cancer patients face spinal metastases disease. Most of the metastatic spinal tumors are developed outside the dura (extradural). Around 70% of the spine tumors occur in the thoracic region, while 20% in the lumbar, and 10% in the neck region. Some of the common symptoms of metastases spinal tumor are back pain, tingling or numbness, and weakness.

Early diagnosis can provide better treatment management of this disorder. Major diagnostic solution provider companies are engaged in developing and launching new medical imaging devices. Introduction and rapid adoption of advanced diagnostic devices are driving the market growth. Increasing research, clinical trials, and new solution development in the field of oncology drive the market. Additionally, growing demand for diagnostic devices and treatment from emerging markets of Asia and Latin America add fuel to the growth of the market.

Some of the key players in this market: F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany), and others.

Market Segments: The global metastases spinal tumor market is segmented on the basis of type, which comprise extradural, metastatic spinal tumors of the bone, and others. On the basis of diagnosis, this market is segmented into laboratory tests, imaging tests, biopsy, and others. Imaging tests includes X-Ray, Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI scan), Angiography, F-18 fluorodeoxyglucose positron emission tomography, and others. Biopsy is sub-segmented into percutaneous needle biopsy, open incisional and excisional biopsy, and others.

On the basis of treatments, the market is segmented into non-operative treatment, surgical treatment, and others. Non operative treatment is sub-segmented into medications, radiation therapy, ablation, chemotherapy, and others. Medications includes anti-inflammatory drugs, narcotics (opioids), corticosteroids, rankl inhibitors and bisphosphonates, and others. Ablation is further sub-segmented into radiofrequency ablation, cryoablation, and others. Surgical treatment is further sub-segmented into minimally invasive surgery, open surgery, and others. Minimally invasive surgery is sub-segmented into vertebral fracture treatments, transarterial chemoembolization, and others. Vertebral fracture treatments is further sub-segmented into vertebroplasty, kyphoplasty (vertebral augmentation), and others. Open surgery includes spinal stabilization surgery, spinal decompression surgery, and others. On the basis of end user, it is segmented into hospitals & clinics, ambulatory surgery centers, academic institutes, research centers, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Duodenoscopes Market Overview, Analysis and Forecasts to 2023

Market Research Future adds new report of “Duodenoscopes Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

The global duodenoscopes market is expected to grow at a CAGR of 6.83% during the forecast period 2017-2023. 

Duodenoscope is a flexible, lighted weighted tubes that are released through the mouth, throat, and stomach into the top of the small intestine. These are specially designed side viewing endoscope for endoscopic retrograde cholangiopancreatography (ERCP) procedures, which will help to diagnose diseases associated with pancreas and bile ducts with the help of fluoroscopic imaging procedure.

Duodenoscope is a more complex device as compared to other endoscopes and is tough to clean and disinfect. These devices play an essential role in the treatment of patients, but there has been some evidences, which showed that some patients were infected with hospital born and other infectious agents, including antibiotic drug-resistant infections due to these devices. In 2013, the Centers for Disease Control and Prevention (CDC) alerted the FDA regarding possible association of multidrug resistant bacterial infections and duodenoscopes. ERCP was associated with infections in 135 patients from January 2013 to December 2014.

The global duodenoscopes market is growing moderately due to increasing prevalence of pancreatic, bile duct cancer tumors, and various gastrointestinal. Additionally, increasing research and development, technological advancements to identify the causes and risk factors associated with transmission of infectious agents from duodenoscopes, and developing new solutions to minimize patient exposure to such infection likely to drive the market growth over the review period.

Some of the key players in this market are FUJIFILM Holdings Corporation, KARL STORZ GmbH & Co. KG, PENTAX Medical, Olympus Corporation, Custom Ultrasonics, Inc., ENDOMED, and SonoScape.

According to the latest WHO report (World Health Organization), in 2015, 8.8 million people died across the globe from cancer, which is nearly 1 in 6 of all the global deaths. According to the WHO, approximately 70% of deaths from cancer occur in low- and middle-income countries. Moreover, according to a report by the World Gastroenterology Organization, (2014), 35-40% of world’s total population had acute or chronic GI complication. However, increasing FDA recalls for duodenoscopes due to challenging cleaning and high-level disinfection procedures and rising multidrug-resistant bacterial infections may affect the growth of the global duodenoscopes market negatively.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Whipple’s Disease Market Overview, Analysis and Forecasts to 2023

Market Research Future adds new report of “Whipple’s Disease Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

The global Whipple’s disease market is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 255.3 million by 2023.

Whipple’s disease (WD) is a rare, chronic, systemic infectious bacterial disease caused by Tropheryma whipplei that affects gastrointestinal system, especially,  the small intestine. The infection may spread to any part of the body but mostly it affects the central nervous system, joints, lungs, heart, and eyes.

Some common symptoms of this disease are weight loss, diarrhea, abdominal cramping and pain, weakness, fatigue, anemia, inflamed joints, and some other less common symptoms. The prevalence is one in one million people. The prevalence of this diseases is more in men than women. Ongoing research and clinical trial to find effective cure drive the growth of market. Advancement in medical technology and increasing awareness about this disease boost the market growth.

Some of the key players in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Henry Schein, Inc. (US), Pfizer Inc. (US)

Regional Analysis of the Global Whipple’s Disease Market: The Americas holds the largest share in the global Whipple’s disease market. North American region, especially, the US dominates the market in this region. It is a rare disease and found in around less than one in million people in US. Some other factors such as advanced medical facilities, ongoing research and clinical trials, and availability of skilled health professionals. Increasing awareness about this disease in Latin America drives market growth in this region.

The new cases of this disease is increasing in Europe. Availability of advanced diagnostic and therapeutic options, high awareness among the European population, and availability of skilled medical professional drive the European market. Availability of cost-effective of treatment in East European countries, for instance, Poland than the other parts of the region add fuel to the growing demand. Owing to availability of cost-effective treatment, patients from Western European countries and Russia travel to East and Central European countries to treat this disease.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Whipple’s Disease Market by Diagnosis
  7. Global Whipple’s Disease Market by Treatment
  8. Global Whipple’s Disease Market by End User
  9. Global Whipple’s Disease Market by Region
  10. Competitive Landscape
  11. Company Profile
  12. Conclusion
  13. Appendix

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Folliculitis Market by Key Players, Growth, Regions and Forecast to 2023

Market Research Future adds new report of “Folliculitis Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Global folliculitis market which is expected to grow at the CAGR of ~4.7% during the forecast period and is estimated to reach USD 561.3 million by 2023.

Folliculitis is very common health problems across the globe. About 3 million cases found per year in the US alone. Folliculitis can be noninfectious or infectious. Although, most of the cases of folliculitis are infectious. Increasing knowledge of folliculitis, rapid adoption of products, and increasing healthcare expenditure are driving this market.

Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), CELGENE CORPORATION (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others.

Market Segments: Global folliculitis market has been segmented on the basis of type which comprise superficial folliculitis, deep folliculitis, and others. Superficial folliculitis is sub-segmented into bacterial folliculitis, hot tub folliculitis (pseudomonas folliculitis), barber’s itch (pseudofolliculitis barbae), pityrosporum folliculitis. Deep folliculitis is sub-segmented into sycosis barbae, gram-negative folliculitis, boils (furuncles) and carbuncles, eosinophilic folliculitis. On the basis of treatments, the market has been segmented into medication, warm compress, medicated shampoo, and others. Medication is sub-segmented into antibiotics, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), antifungals, antivirals, and others. On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.

Study objectives of global folliculitis market: To provide detailed analysis of the global folliculitis market structure with historical and forecast revenue for the next six years of the various segments and sub-segments. To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global folliculitis market. To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia-Pacific, and Middle East & Africa. To provide detailed analysis of the market segmented by type, treatment, end user, and its sub-segments. To provide a detailed analysis of global folliculitis market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc. To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

Regional analysis of global folliculitis market: Considering the global scenario of the market, the Americas is holding largest market share. Some major factors are driving the growth in America such as large amount of money invested in R&D, and clinical trials. European market is second largest and countries like Germany and UK are holding largest market share. Increasing healthcare spending is major factor for Asia Pacific folliculitis market. While due to lack of knowledge of the disease and limited access to the healthcare facilities, Middle East and Africa is growing slower than the global average.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Surgical Equipment Market Outlook and Global Foresight to 2021

Market Research Future adds new report of “Global Surgical Equipment Market Research Report – Forecast to 2021” it contains Company information, geographical data and Table of Content

Global Surgical Equipment Market– Forecast to 2021 The report firstly introduced Global Surgical Equipment Market including classification, application and industry chain overview; Then we deeply analyzed global growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc.

A Surgical Equipment is a specially designed tool or device for performing specific actions of carrying out desired effects during a surgery or operation, such as modifying biological tissue, or to provide access for viewing it. Over time, many different kinds of Surgical Equipment s and tools have been invented. Some Surgical Equipment s are designed for general use in surgery, while others are designed for a specific procedure or surgery. Accordingly, the nomenclature of Surgical Equipment s follows certain patterns, such as a description of the action it performs (for example, scalpel, hemostat), the name of its inventor(s) (for example, the Kocher forceps) or a compound scientific name related to the kind of surgery.

In the end, the report introduced Surgical Equipment market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Global Surgical Equipment Market. We are thankful for the support and assistance from Global Surgical Equipment Market. Industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report for Global Surgical Equipment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Brief TOC

  1. Introduction
  2. Research Methodology
  3. Report Excerpt
  4. Forecast Indicators
  5. Market Analysis
  6. Global Surgical Equipment Market, By Type
  7. Geographical Explorations
  8. Competitive Analysis
  9. Company Profiles
  10. Appendix

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Genetic Testing Market Overview – Key Futuristic Trends and Opportunities

Market Research Future adds new report of “Genetic Testing Market- Global Forecast To 2023” it contains Company information, geographical data and Table of Content

The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016. It is growing at the CAGR of ~9.8% during the forecast period.

Genetic testing involves the use of laboratory methods to study the genes inherited from mother or father. These tests may be used to identify increased risks of health problems, to diagnose the mutations in the genes, to choose treatments, or to assess responses to treatment. The Global Genetic testing market is growing moderately.

Some of the key players in this market are: Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Illumina Inc. (US), Myriad Genetics (US), PerkinElmer Inc. (US), QIAGEN N.V. (Germany), and Quest Diagnostics (US)

Market Segments:  Global genetic testing market has been segmented on the basis of type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016. On the basis of method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016. On the basis of type of test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016. On the basis of indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.

The report for global genetic testing market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Genetic Testing Market By Type
  7. Global Genetic Testing Market By Method
  8. Global Genetic Testing Market By Type Of Test
  9. Global Genetic Testing Market By Indication
  10. Global Genetic Testing Market By Region
  11. Company Profile

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com